Breaking News on Global Pharmaceutical Technology & Manufacturing

Hot Topics > Globalisation



When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment.

Takeda inaugurates €100m German oral solid dose plant

20-Jun-2017 - Takeda has completed a €100m ($112m) oral solid dosage production facility in Germany.

Roquette expands into Brazilian pharma excipient space

06-Jun-2017 - Ingredients manufacturer Roquette says it will acquire Blancer’s Brazil-based excipient division, Itacel, to meet market demand.

Russian partnerships: Pfizer and NovaMedica break ground on aseptic plant

01-Jun-2017 - Pfizer and NovaMedica have broken ground on a manufacturing facility in Kaluga set to supply the Russian market with sterile injectable drugs.

AB Science suspends French masitinib trials after ANSM finds deviations

15-May-2017 - AB Science SA has halted French trials of its Ph III drug candidate masitinib after regulators uncovered good clinical practice (GCP) and pharmacovigilance deviations in an earlier study.

Unused €107m pilot plant in France to be demolished, says Sanofi

11-May-2017 - Sanofi says it will demolish a pilot plant in Montpellier that has been left idle since its completion in 2011, citing its evolving biologics-focused portfolio.

US FDA sends Biocon Bangalore plant 483 with 8 observations

10-May-2017 - Issues in the quality testing of drug substance and product were among eight observations cited in a Form 483 following an inspection at Biocon’s site last month.

UK firms should look to global opportunities to offset Brexit woes, says biotech CEO

18-Apr-2017 - UK life science companies must become global to help offset staffing and funding problems potentially caused by Brexit, says Arecor CEO Sarah Howell.

Patheon ramping up former Roche site to fulfil demand for Western APIs

20-Mar-2017 - Patheon believes it can triple revenues at its recently acquired Roche facility in South Carolina due to a shortage of Western active pharmaceutical ingredient (API) capacity.

Apotex expanding US footprint with $184m investment

09-Mar-2017 - Generics maker Apotex will construct a manufacturing and packaging facility as part of a $184m US expansion.

Allergan's €42m investment boosts Irish manufacturing and jobs

02-Mar-2017 - Allergan has committed €42m ($44m) to increase capacity and capabilities at two manufacturing facilities in Ireland.

GSK on America First: US will not be able to own every part of supply chain

13-Feb-2017 - GSK has warned that Donald Trump’s plan to encourage US drug production through import tax hikes must take the global nature of pharma supply chains into account.

Cambrex riding high on demand for Western innovator APIs

06-Feb-2017 - Limited US manufacturing capacity and a growing demand for innovator APIs will drive continued growth, says Cambrex.

Biocon wins $68m Malaysian contract for biosimilar insulin and pen supply

26-Jan-2017 - Biocon has been awarded a three-year contract to supply recombinant human insulin formulations made at its Malaysian facility to the country’s Ministry of Health.

GAO wants US FDA to show benefits of overseas inspections

18-Jan-2017 - The US FDA is inspecting more foreign plants but has not shown if its efforts have improved the quality of API and drug imports according to a GAO report.

Day 2

JP Morgan Conference: Trumpcare, moonshots and M&A

10-Jan-2017 - If you're not going to San Francisco, in-Pharmatechnologist brings you a smattering of the best tweets from the 35th Annual JP Morgan Healthcare Conference.

Catalent joins industry group supply chain initiative

12-Dec-2016 - Catalent has become the first CDMO to join the PSCI – a voluntary industry initiative focused on the social, environmental and economic impact of the supply chain.

GSK exiting Australian OTC site: over 200 jobs to be lost

07-Nov-2016 - GSK says it remains dedicated to Australian despite announcing plans to shutter a painkiller manufacturing site in Sydney.

Recipharm invests €1.2m in Italian small-scale API capabilities

02-Nov-2016 - Smaller drugmakers are shifting away from generics and towards niche new molecules says Recipharm, which has expanded a small-scale API facility to feed demand.

CFDA: reports of clinical trial data fraud 'not fact based'

25-Oct-2016 - The Chinese Food and Drug Administration (CDFA) has fired back on lack of context in media reporting “80% of China’s clinical trial data are fraudulent.”

Dispatches from CPhI Worldwide

UK-based CMOs benefitting from currency exchange post-Brexit vote

07-Oct-2016 - UK-based contract manufacturers are benefitting from the weak pound following the country’s referendum in June, but the long-term impact of Brexit is still unknown.

AbbVie API plant opens in Singapore as first part of larger $320m site

29-Sep-2016 - AbbVie has opened an oncology and women’s health API plant, part of its planned 120,000m2 small and large molecule manufacturing site in Singapore.

Attention Amgen: Canada OKs Samsung Bioepis and Merck's Enbrel biosimilar

12-Sep-2016 - Canada has approved Brenzys, its first biosimilar version of Amgen’s Enbrel (etanercept) made by Korean drugmaker Samsung Bioepis.

India turns to certification in pharma manufacturing quality drive

01-Sep-2016 - India's government has launched a certification programme aimed at tightening up quality standards in its domestic drug industry.

Hikma continues beefing up US and European manufacturing capabilities

29-Aug-2016 - Hikma invested over $25m in its US facilities in the first half 2016, and plans to use excess capacity at a former Boehringer Ingelheim plant for contract manufacturing.

AstraZeneca: Retaining current regulatory procedures crucial, post-Brexit

01-Aug-2016 - AstraZeneca says it will be critical to avoid duplicated regulatory efforts and costs once the UK leaves the European Union.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...